ダウンロード数: 215

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
67_6_245.pdf1.02 MBAdobe PDF見る/開く
タイトル: 緩和的な放射線照射が奏効した終末期前立腺癌の2例
その他のタイトル: Two Cases of Palliative Radiation Therapy for Prostate Cancer Patients in the Terminal Phase
著者: 諸岡, 大地  KAKEN_name
橋本, 浩平  KAKEN_name
小林, 皇  KAKEN_name
田中, 俊明  KAKEN_name
舛森, 直哉  KAKEN_name
著者名の別形: MOROOKA, Daichii
HASHIMOTO, Kohei
KOBAYASHI, Ko
TANAKA, Toshiaki
MASUMORI, Naoya
キーワード: Prostate cancer
palliative
radiation
terminal
lymph node metastasis
発行日: 30-Jun-2021
出版者: 泌尿器科紀要刊行会
誌名: 泌尿器科紀要
巻: 67
号: 6
開始ページ: 245
終了ページ: 248
抄録: Herein we report two cases of palliative radiation therapy for retroperitoneal lymph node metastasis (RLNM) causing annoying leg edema in castration-resistant prostate cancer (CRPC) patients in the terminal phase. [Case 1] A 53-year-oldman with T3bN0M1a prostate cancer was treated with androgen deprivation therapy (ADT). After 9 months, he developed CRPC with local progression that required local radiation therapy (75.6 Gy/36 fr). Disease progression after life-prolonging therapies was followed only by best supportive care (BSC). Radiation therapy (40 Gy/20 fr) was performed for the RLNM due to which he suffered from painful leg edema. Although the painful leg edema was alleviated, he died of prostate cancer after 2 months. [Case 2] A 71-year-oldman with T4N1M1a prostate cancer was treated with ADT plus bicalutamide. After 10 months, he developed CRPC. He was treated with only BSC for disease progression after life-prolonging therapies. He had RLNM that caused painful leg edema, making it difficult for him to stretch and lie on his back. Radiation therapy (16 Gy/2 fr) was performed for the RLNM. His condition improved enough that he was able to move to a wheelchair and lie on his back. However, he died of prostate cancer without recurrence of the painful leg edema after one month. Our experience with these two CRPC patients with severe leg edema due to the RLNM indicates that radiation therapy for lymph node metastasis may be included as one of the treatment options even for terminal disease.
著作権等: 許諾条件により本文は2022-07-01に公開
DOI: 10.14989/ActaUrolJap_67_6_245
URI: http://hdl.handle.net/2433/264502
PubMed ID: 34265900
出現コレクション:Vol.67 No.6

アイテムの詳細レコードを表示する

Export to RefWorks


出力フォーマット 


このリポジトリに保管されているアイテムはすべて著作権により保護されています。